Multiple cutaneous basal cell carcinomas: Glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual

被引:88
|
作者
Lear, JT
Heagerty, AHM
Smith, A
Bowers, B
Payne, CR
Smith, CAD
Jones, PW
Gilford, J
Yengi, L
Alldersea, J
Fryer, AA
Strange, RC
机构
[1] KEELE UNIV,N STAFFORDSHIRE HOSP,POSTGRAD MED SCH,CTR PATHOL & MOL MED,STOKE ON TRENT,STAFFS,ENGLAND
[2] N STAFFORDSHIRE HOSP,DEPT DERMATOL,STOKE ON TRENT,STAFFS,ENGLAND
[3] WILLIAM HARVEY HOSP,ASHFORD,KENT,ENGLAND
[4] UNIV EDINBURGH,SCH MED,DEPT PATHOL,EDINBURGH,MIDLOTHIAN,SCOTLAND
[5] UNIV KEELE,DEPT MATH,KEELE ST5 5BG,STAFFS,ENGLAND
关键词
D O I
10.1093/carcin/17.9.1891
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The genetic factors that mediate the pathogenesis of multiple primary cutaneous basal cell carcinomas (BCC) are largely unclear. Thus, some patients suffer many BCC (>30) and/or rapid accrual (number of tumours/year from first presentation) of further lesions. We have studied, in 827 English Caucasians, the influence of polymorphism in carcinogen-metabolizing enzymes on susceptibility to this cancer. Accordingly, we describe, first, a cross-sectional analysis of the influence of GSTM1, GSTT1, CYP2D6 and CYP1A1 genotypes on tumour numbers, and secondly, a longitudinal analysis. In 169 of these cases, of the effect of these genes on tumour accrual. We have confirmed the expected importance of age and number of lesions at presentation, and male gender and skin type as risk factors. Furthermore, the cross-sectional analysis showed CYP1A1 m(1)m(1) (P = 0.004; rate ratio 1.242) and CYP2D6 EM (P < 0.001, rate ratio 1.266) are associated with increased numbers of BCC. The longitudinal study showed, after adjustment for age and tumour number at presentation, that GSTT1 null (P < 0.001, rate ratio 2.677) and CYP2D6 EM (P < 0.001, rate ratio 2.154) were significant determinants of accrual while CYP1A1 Ile/Ile was associated with slower accrual than the Ile/Val and Val/Val genotypes (P = 0.008, rate ratio 0.690). We believe these are the first genetic factors to be associated with tumour accrual. No significant interactions between genotypes were identified, though the combinations GSTM1 null/skin type 1 (P < 0.001, rate ratio 2.702), CYP2D6 EM/male gender (P = 0.049, rate ratio 1.279) and CYP2D6 EM/blue+green eyes (P = 0.046, rate ratio 1.388) influenced tumour numbers. Previous studies indicate the importance of effective repair of UV-damaged DNA in the pathogenesis of multiple BCC; indeed the influence of GSTM1 may result from its ability to utilize 5'-hydroxymethyluracil. However, the finding that CYP2D6 and CYP1A1 influence tumour numbers and accrual indicates detoxification of unknown molecules is important and supports the view that factors other than UV are important in the pathogenesis of BCC.
引用
收藏
页码:1891 / 1896
页数:6
相关论文
共 50 条
  • [31] CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population
    Ertan Altayli
    Sezgin Gunes
    Ali Faik Yilmaz
    Serdar Goktas
    Yuksel Bek
    International Urology and Nephrology, 2009, 41 : 259 - 266
  • [32] Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India
    Sobti, RC
    Al-Badran, A
    Sharma, S
    Sharma, SK
    Krishan, A
    Mohan, H
    CANCER GENETICS AND CYTOGENETICS, 2005, 156 (01) : 68 - 73
  • [33] Polymorphisms of glutathione S-transferase Mu1 (GSTM1)and Theta1 (GSTT1) genes in multiple myeloma
    Ortega, MM
    Nascimento, H
    Melo, MB
    Teori, MT
    Costa, FF
    Lima, CSP
    ACTA HAEMATOLOGICA, 2003, 109 (02) : 108 - 109
  • [34] Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population
    Uhm, Yoon Kyung
    Yoon, Seo Hyun
    Kang, Ik Joon
    Chung, Joo-Ho
    Yim, Sung-Vin
    Lee, Mu-Hyoung
    LIFE SCIENCES, 2007, 81 (03) : 223 - 227
  • [35] Genetic Polymorphisms of Glutathione S-Transferase Genes GSTM1, GSTT1 and Risk of Hepatocellular Carcinoma
    Song, Kang
    Yi, Jiayong
    Shen, Xizhong
    Cai, Yu
    PLOS ONE, 2012, 7 (11):
  • [36] Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk:: A prospective study
    Gertig, DM
    Stampfer, M
    Haiman, C
    Hennekens, CH
    Kelsey, K
    Hunter, DJ
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (11) : 1001 - 1005
  • [37] CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population
    Altayli, Ertan
    Gunes, Sezgin
    Yilmaz, Ali Faik
    Goktas, Serdar
    Bek, Yuksel
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2009, 41 (02) : 259 - 266
  • [38] Analysis of the influence of glutathione S-transferase (GSTM1 and GSTT1) genes on the risk of essential hypertension
    Nassereddine, Sanaa
    Habbal, Rachida
    Kassogue, Yaya
    Kaltoum, Ait Boujmia Oum
    Farah, Korchi
    Majda, Haraka
    Rhizlane, Abou Elfath
    Nadifi, Sellama
    Dehbi, Hind
    ANNALS OF HUMAN BIOLOGY, 2021, 48 (7-8) : 585 - 589
  • [39] EVALUATION OF GLUTATHIONE S-TRANSFERASE GSTM1 AND GSTT1 POLYMORPHISMS AND METHYLMERCURY METABOLISM IN AN EXPOSED AMAZON POPULATION
    Mazzaron Barcelos, Gustavo Rafael
    de Marco, Katia Cristina
    Grotto, Denise
    Valentini, Juliana
    Garcia, Solange Cristina
    Leite Braga, Gilberto Ubila
    Barbosa, Fernando, Jr.
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2012, 75 (16-17): : 960 - 970
  • [40] Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility
    Curran, JE
    Weinstein, SR
    Griffiths, LR
    CANCER LETTERS, 2000, 153 (1-2) : 113 - 120